Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorYale University
About this trial
The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.
Eligibility criteria
Qualifiers
diagnosis of T2D for at least one year
recent 3 month-HbA1c, 8-11%
ownership of a smartphone
English or Spanish speaking.
Disqualifiers
pregnant
not available or willing to use CGM or study device/platform
serious medical conditions or active thought disorders (e.g., terminal cancer, schizophrenia)
Trial design
Treatments tested in this trial
- Integrated Digital Health (IDH) platform
- Provider engagement
Treatment groups
300 Participants
are divided into 3 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov